Since its founding in 2005, phenox has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases.
Phenox's products are used by endovascular specialists to treat ischemic and hemorrhagic stroke. The company offers a growing portfolio of innovative treatment options, including the primary interventional technologies used today.
The product range includes pREset, a mechanical thrombectomy device, the p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections as well as the pCONus Bifurcation Aneurysm Implant which is intended to treat complex, wide neck intracranial bifurcation aneurysms.
The P64 flow modulation device is primarily aimed at neuro use but could be used elsewhere. This is an extremely fine meshed stent that could be placed across the neck of a small aneurysm. The flow dynamics are sufficiently changed to allow thrombosis of the aneurysm. The device is deployed...
read full descriptionWhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.